Medications for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexMale
Age40-70
SponsorTanta University
About this trial
The main objective of this prospective randomized controlled study is to compare safety and efficacy of Vardenafil versus Tadalafil versus Tamsulosin in terms of (voiding function, sexual function and quality of life) in the management of moderate BPH related LUTS.
Eligibility criteria
Qualifiers
Sexually active patients .
ModerateBPH related LUTS ( bengin prostatic hyperplasia related lower urinary tract symtoms ) i.e: (international prostatic symptom score 8 to 19 : the higher score is the worse symptoms ).
Patients accepted medical treatment and completed 12 weeks on medical treatment and strict follow up .
Disqualifiers
Indication for combined therapy as prostate size over 40 gm .
Gross hematuria.
Refractory urine retention .
Bilateral hydro-ureteronephrosis or renal insufficiency secondary to bengin prostatic hyperplasia.
Trial design
Treatments tested in this trial
- Vardenafil 5 Mg Oral Tablet
Treatment groups
150 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov